Free Motion for Miscellaneous Relief - District Court of Delaware - Delaware

Case 1:05-cv-00337-SLR

Document 159-2

Filed 10/22/2007

Page 1 of 5

EXHIBIT A

Case 1:05-cv-00337-SLR

Document 159-2

Filed 10/22/2007

Page 2 of 5

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC., ASTELLAS U.S. LLC, and ASTELLAS PHARMA US, INC., Plaintiffs, v. SICOR INC. and SICOR PHARMACEUTICALS, INC., Defendants. ) ) ) ) ) ) ) ) ) ) ) ) )

Civil Action No. 05-0337-SLR

JUDGMENT AND INJUNCTION ON CONSENT Plaintiffs Astellas US LLC and Astellas Pharma US, Inc. (hereinafter collectively "Astellas") and King Pharmaceuticals Research and Development, Inc. (hereinafter "King") and Defendants Sicor Inc. and Teva Parenteral Medicines, Inc. (formerly known as Sicor Pharmaceuticals, Inc.)" (hereinafter collectively "Sicor"), have agreed to terms and conditions representing a negotiated settlement of this action and have set forth those terms and conditions in a Settlement Agreement. Now the parties, by their respective undersigned attorneys, hereby stipulate and consent to entry of judgment in this action as follows: It is HEREBY ORDERED, ADJUDGED, AND DECREED:

Case 1:05-cv-00337-SLR

Document 159-2

Filed 10/22/2007

Page 3 of 5

1.

This Court has jurisdiction over the subject matter of this action and has personal jurisdiction over the parties.

2.

With respect to Count II of the Complaint herein, seeking a declaratory judgment of infringement under 35 U.S.C. § 271(b) and (c), Sicor admits for itself and its Affiliates (as defined in the Settlement Agreement) that claims 23 as read through claim 17, 23 as read through claim 18, and 43 of U.S. Patent No. 5,070,877 (the "Asserted Claims") would be infringed by use, importation, offer for sale, or sale of the adenosine product, Adenosine Injection, USP labeled for use in myocardial perfusion imaging described in Sicor's Abbreviated New Drug Application No. 77-425 (the "Sicor ANDA Product"), except as provided in the Settlement Agreement.

3.

Sicor further admits for itself and its Affiliates (as defined in the Settlement Agreement) that the Asserted Claims are valid and enforceable as to the Sicor ANDA Product and any product only colorably different therefrom.

4.

Sicor and its Affiliates (as defined in the Settlement Agreement) shall not market the Sicor ANDA Product except as provided in the Settlement Agreement.

5.

Counts I and III of the Complaint herein, seeking a judgment of infringement under 35 U.S.C. § 271(e)(2), are dismissed without prejudice.

6.

This Court retains jurisdiction to enforce or supervise performance under this Judgment and Injunction on Consent and the Settlement Agreement.

2

Case 1:05-cv-00337-SLR

Document 159-2

Filed 10/22/2007

Page 4 of 5

7.

Each party shall bear its own costs and attorneys' fees.

Dated: October 22, 2007

/s/ Richard K. Herrmann Approved as to form: Richard K. Herrmann #405 Mary B. Matterer # 2696 MORRIS JAMES LLP 500 Delaware Avenue, Suite 1500 Wilmington, DE 19801-1494 (302) 888-6800 [email protected] [email protected] Charles E. Lipsey FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP Two Freedom Square 11955 Freedom Drive Reston, VA 20190-5675 (571) 203-2700 Susan H. Griffen David P. Frazier FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP 901 New York Avenue Washington, D.C. 20001-4413 (202) 408-4000 Attorneys for Plaintiffs Astellas US LLC and Astellas Pharma US, Inc.

/s/ Karen L. Pascale Approved as to form: Josy W. Ingersoll #1088 Karen L. Pascale #2903 YOUNG CONAWAY STARGATT & TAYLOR, LLP The Brandywine Building 1000 West Street Wilmington, DE 19801 (302) 571-6672 [email protected] [email protected] David M. Hashmall, P.C. Annemarie Hassett GOODWIN PROCTOR LLP 599 Lexington Avenue New York, NY 10022 [email protected] [email protected] Attorneys for Defendants Sicor Inc. and Sicor Pharmaceuticals, Inc.

3

Case 1:05-cv-00337-SLR

Document 159-2

Filed 10/22/2007

Page 5 of 5

/s/ Paul E. Crawford Approved as to form: Paul E. Crawford #493 Patricia Smink Rogowski #2632 CONNOLLY BOVE LODGE & HUTZ LLP 1007 North Orange Street Wilmington, DE 19801 (302) 658-9141 [email protected] F. Dominic Cerrito Brian Poissant JONES DAY 222 E. 41st Street New York, NY 10017 (212) 326-3939 Attorneys for Plaintiff King Pharmaceuticals Research and Development, Inc.

SO ORDERED this ____ day of ______________ , 2007.

______________________________ United States District Judge

4